Ipca Laboratories Ltd. Fundamental & Technical Research, Share Price Today

NSE : IPCALAB
NIFTY : Nifty 500
NIFTY SECTOR : Nifty Pharma

About Company

IPCA Laboratories Limited incorporated in the year 1949, is integrated pharmaceutical company manufacturing and marketing various formulations and many API’s covering various therapeutic segments. The products of the company are sold in many countries across the globe. The company has numerous manufacturing units in India manufacturing API’s and formulations for the world market. The company is one of the largest suppliers of these APIs worldwide with manufacturing leadership in many APIs globally. It has various APIs and formulations manufacturing facility across the globe. The company has leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy in India.

Market Cap. ₹33,008 Cr.

52 Week - High/Low ₹1,756/1,052

P/E Ratio 42.28

P/B Ratio 5.20

Enterprise Value ₹33,686 Cr.

ROE % 8.68

RSI Value 40.21

EMA 50 1430.3

EMA 200 1423.29

Net Profit 530 Cr.

Net Profit 3year growth -53.5 Cr.

Net Profit 3 year (back) 1,141 Cr.

Debt to Equity 0.18 %

EPS Growth TTM 41.8 %

Current Ratio 2.31 %

100 Day SMA 1,500 Rs.

200 Day SMA 1,448 Rs.

21 Day SMA 1,384 Rs.

50 Day SMA 1,417 Rs.

Book Value 250 Rs.

EV/EBITDA Ratio 24

QoQ EPS Growth 10 %

QoQ Operating Profit Growth 2 %

QoQ Sales Growth -8 %

Sales Latest Quarter 1,663 Cr.

YoY Sales Growth 10 %

Market Cap. ₹33,008 Cr.

52 Week - High/Low ₹1,756/1,052

P/E Ratio 45.24

P/B Ratio 5.21

Enterprise Value ₹33,726 Cr.

ROE % 8.7

RSI Value 40.21

EMA 50 1430.3

EMA 200 1423.29

Net Profit 547 Cr.

Net Profit 3year growth 9.7 Cr.

Net Profit 3 year (back) 1,140 Cr.

Debt to Equity 0.22 %

EPS Growth TTM 29.26 %

Current Ratio 2.35 %

100 Day SMA 1,500 Rs.

200 Day SMA 1,448 Rs.

21 Day SMA 1,384 Rs.

50 Day SMA 1,417 Rs.

Book Value 250 Rs.

EV/EBITDA Ratio 22

QoQ EPS Growth 8 %

QoQ Operating Profit Growth 5 %

QoQ Sales Growth -5 %

Sales Latest Quarter 2,245 Cr.

YoY Sales Growth 9 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages